Dermatological toxicities, HTN, hemorrhage, wound healing complications, cardiac ischemia &/or infarction, QT/QTc interval prolongation, GI perforation, hepatic impairment. Regularly monitor for changes in prothrombin time, INR & clinical bleeding episodes w/ concomitant warfarin use. Hypocalcaemia, TSH supression in differentiated thyroid carcinoma (DTC). Concomitant use w/ compd metabolized/eliminated predominantly by the UGT1A1 pathway, docetaxel, neomycin. Pregnancy & lactation. Childn.